Ocera Therapeutics
Biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
HQ location
Palo Alto, United States
Website
Launch date
Enterprise value
$42m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
$42.0m Valuation: $42.0m | Acquisition | ||
| Total Funding | 000k | ||
Silicon Valley Bank(exited)
Greenspring Associates(exited)
Oxford Finance(exited)
RA Capital Management(exited)
Venrock(exited)
Deerfield Partners(exited)
Vivo Capital(exited)
Three Arch Partners(exited)
InterWest Partners(exited)
Great Point Partners(exited)
Domain Associates(exited)
Redmont Capital(exited)
Thomas McNerney & Partners(exited)
Sofinnova(exited)
Wasatch Advisors(exited)
FinTech Innovation Lab(exited)
Cross Creek(exited)
CDIB BioScience Ventures(exited)
GeneChem(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.